id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2003-E-0221-0005,FDA,FDA-2003-E-0221,"Certificate Extending Patent Term from U.S. Patent and Trademark Office to Finnegan, Henderson, Farabow, Garrett & Dunner. L.L.P.",Rule,Certificate Extending Patent Term,2006-09-15T04:00:00Z,2006,9,,,2025-10-30T19:44:54Z,,0,0,090000648048cf06
FDA-2003-E-0221-0004,FDA,FDA-2003-E-0221,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2004-10-21T04:00:00Z,2004,10,,,2025-10-30T19:41:10Z,,0,0,090000648048cf03
FDA-2003-E-0221-0003,FDA,FDA-2003-E-0221,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2004-01-27T05:00:00Z,2004,1,,,2025-10-30T19:24:30Z,,0,0,090000648048cefd
FDA-2003-E-0221-0002,FDA,FDA-2003-E-0221,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2003-11-24T05:00:00Z,2003,11,,,2025-10-30T19:01:28Z,,0,0,090000648048cefa
FDA-2003-E-0221-0001,FDA,FDA-2003-E-0221,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2003-09-25T04:00:00Z,2003,9,,,2025-10-30T18:59:21Z,,0,0,090000648048ce94